Dioscin's antiviral effect in vitro

Virus Research

Volumn 172, Issue 1-2, 2013, Pages 9-14

  Liu, Chaohong ^a   Wang, Yun ^a   Wu, Chunchen ^a   Pei, Rongjuan ^a   Song, Jianhua ^a   Chen, Shiyun ^a   Chen, Xinwen ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

Adenovirus; Antiviral properties; CAR; Dioscin; HBV; VSV

Indexed keywords

ANTIVIRUS AGENT; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; DIOSCIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ADENOVIRUS; ADENOVIRUS INFECTION; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN HEK293; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOXICITY TESTING; VESICULAR STOMATITIS VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

ADENOVIRIDAE; ANTIVIRAL AGENTS; CELL LINE; DIOSCOREA; DIOSGENIN; HEPATITIS B VIRUS; HUMANS; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; VESICULOVIRUS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

ADENOVIRIDAE; DIOSCOREA ALATA; DIOSCOREA BULBIFERA; HEPATITIS B VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 84873749830     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.12.001     Document Type: Article

References (23)

1. Arbuthnot P., Carmona S., Ely A. Exploiting the RNA interference pathway to hepatitis B virus replication. Liver International 2005, 25:9-15.
2. Bloor S., Maelfait J., Krumbach R., Beyaert R., Randow F. Endoplasmic reticulum chaperone gp96 is essential for infection with vesicular stomatitis virus. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:6970-6975.
3. Blumberg B.S., Millman I., Venkateswaran P.S., Thyagarajan S.P. Hepatitis B virus and hepatocellular carcinoma: treatment of HBV carriers with Phyllanthus amarus. Cancer Detection and Prevention 1989, 14:195-201.
4. Cheng H.Y., Lin T.C., Yang C.M., Wang K.C., Lin C.C. Mechanism of action of the suppressing of herpes simplex virus type 2 replication by pterocarnin A. Microbes and Infection 2004, 6:738-744.
5. Coil D.A., Miller A.D. Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus. Journal of Virology 2004, 78:10920-10926.
6. De Geyter E., Swevers L., Soin T., Geelen D., Smagghe G. Saponins do not affect the ecdysteroid receptor complex but cause membrane permeation in insect culture cell lines. Journal of Insect Physiology 2012, 58:18-23.
7. Freimuth P., Philipson L., Carson S.D. The coxsackievirus and adenovirus receptor. Current Topics in Microbiology and Immunology 2008, 323:67-87.
8. Fung S.K., Luk A.S. Viral hepatitis. Current Opinion in Gastroenterology 2003, 20:241-247.
9. Funke C., Farr M., Werner B., Dittmann S., Uberla K., Piper C., Niehaus K., Horstkotte D. Antiviral effect of Bosentan and Valsartan during coxsackievirus B3 infection of human endothelial cells. Journal of General Virology 2010, 91:1959-1970.
10. Hassan M.M., Li D., El-Deeb A.S., Wolff R.A., Bondy M.L., Davila M., Abbruzzese J.L. Association between hepatitis B virus and pancreatic cancer. Journal of Clinical Oncology 2008, 26:4557-4562.
11. He T.C., Zhou S.B., Luis T. A simplified system for generating recombinant adenoviruses. Proceedings of the National Academy of Sciences 1998, 95:2509-2514.
12. Jalal H., Bibby D.F., Tang J.W., Bennett J., Kyriakou C., Peggs K. First reported outbreak of diarrhea due to adenovirus infection in a hematology unit for adults. Journal of Clinical Microbiology 2005, 43:2575-2580.
13. Letchworth G.J., et al. Vesicular stomatitis. Veterinary Journal (BR) 1999, 157:239-260.
14. Maynard M., Parvaz P., Durantel S., Chevallier M., Chevallier P., Lot M., Trepo C., Zoulim F. Sustained HBsAg seroconversion during lamivudine and adefovir dipiviox combination therapy for lamivudine failure. Journal of Hepatology 2005, 42:279-281.
15. Nemerow G.R., Stewart P.L. Role of αv integrins in adenovirus cell entry and gene delivery. Microbiology and Molecular Biology Reviews 1999, 63:725-734.
16. Pei S., Zhang Y., Xu H., Chen X., Chen S. Inhibition of the replication of hepatitis B virus in vitro by pu-erh tea extracts. Journal of Agricultural and Food Chemistry 2011, 59:9927-9934.
17. Ristig M.B., Crippin J., Aberg J.A., Powderly W.G., Lisker-Melman M., Kessels L., Tebas P. Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed. Journal of Infectious Diseases 2002, 186:1844-1847.
18. Schlegel R., Tralka T.S., Willingham M.C., Pastan I. Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site?. Cell 1983, 32:639-646.
19. Sells M.A., Chen M.L., Acs G. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proceedings of the National Academy of Sciences of the United States of America 1987, 84:1005-1009.
20. Shin M.S., Kang E.H., Lee Y.I. A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes. Antiviral Research 2005, 67:163-168.
21. Sprengers D., Janssen H.L. Immuno modulatory for chronic hepatitis B virus infection. Fundamental and Clinical Pharmacology 2005, 19:17-26.
22. van de Loosdrecht A.A., Nennie E., Ossenkoppele G.J., Beelen R.H., Langenhuijsen M.M. Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. Journal of Immunological Methods 1991, 141:15-22.
23. Wang Z.Y., Cheng Y., Wang N., Wang D.M., Li Y.W., Han F., Shen, Jian G., Yang D.P., Guan X.Y., Chen J.P. Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins. Cancer Biology & Therapy 2012, 13:138-147.